BioAge Labs, Inc. (BIOA)
8.18
-0.30
(-3.54%)
USD |
NASDAQ |
Sep 15, 16:00
8.41
+0.23
(+2.81%)
After-Hours: 04:29
BioAge Labs Price : 8.18 for Sept. 15, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | 8.48 | 8.50 | 8.02 | 8.18 | 643573.0 |
| Sep 14, 2026 | 8.52 | 8.635 | 8.39 | 8.48 | 563393.0 |
| Sep 11, 2026 | 8.71 | 8.89 | 8.28 | 8.49 | 672078.0 |
| Sep 10, 2026 | 9.07 | 9.07 | 8.60 | 8.65 | 492865.0 |
| Sep 09, 2026 | 9.38 | 9.40 | 9.02 | 9.17 | 488346.0 |
| Sep 08, 2026 | 9.60 | 9.645 | 9.324 | 9.395 | 388071.0 |
| Sep 04, 2026 | 9.39 | 9.76 | 9.39 | 9.59 | 314854.0 |
| Sep 03, 2026 | 9.90 | 9.98 | 9.415 | 9.50 | 407283.0 |
| Sep 02, 2026 | 9.59 | 10.05 | 9.425 | 9.73 | 541262.0 |
| Sep 01, 2026 | 9.28 | 9.72 | 9.150 | 9.52 | 605312.0 |
| Aug 31, 2026 | 9.61 | 9.63 | 9.20 | 9.50 | 1.033M |
| Aug 28, 2026 | 10.06 | 10.25 | 9.595 | 9.65 | 452194.0 |
| Aug 27, 2026 | 9.93 | 10.23 | 9.80 | 10.08 | 475429.0 |
| Aug 26, 2026 | 10.03 | 10.03 | 9.76 | 9.84 | 504282.0 |
| Aug 25, 2026 | 9.55 | 10.13 | 9.55 | 10.11 | 499332.0 |
| Aug 24, 2026 | 9.57 | 9.65 | 9.16 | 9.38 | 661583.0 |
| Aug 21, 2026 | 9.78 | 9.916 | 9.48 | 9.48 | 453445.0 |
| Aug 20, 2026 | 10.64 | 10.72 | 9.63 | 9.69 | 776793.0 |
| Aug 19, 2026 | 10.69 | 10.88 | 10.38 | 10.75 | 412251.0 |
| Aug 18, 2026 | 10.31 | 10.75 | 10.19 | 10.46 | 478458.0 |
| Aug 17, 2026 | 10.60 | 10.71 | 10.14 | 10.40 | 671938.0 |
| Aug 14, 2026 | 10.37 | 10.63 | 10.10 | 10.60 | 444369.0 |
| Aug 13, 2026 | 10.62 | 10.86 | 10.37 | 10.43 | 536932.0 |
| Aug 12, 2026 | 10.78 | 10.95 | 10.43 | 10.48 | 614579.0 |
| Aug 11, 2026 | 11.49 | 11.55 | 10.44 | 10.67 | 761071.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Eli Lilly & Co. | 1136.11 |
| Pfizer Inc. | 27.55 |
| Oramed Pharmaceuticals, Inc. | 4.62 |
| Liquidia Corp. | 65.72 |
| Neumora Therapeutics, Inc. | 0.8313 |
Price Related Metrics
| PS Ratio | 31.46 |
| PEG Ratio | -0.5078 |
| Price to Book Value | 0.9988 |
| Earnings Yield | -29.18% |
| Market Cap | 374.46M |
| PEGY Ratio | -0.5078 |